PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtype.
Guarneri, Valentina, Dieci, Maria Vittoria, Bisagni, Giancarlo, Brandes, Alba A, Frassoldati, Antonio, Cavanna, Luigi, Musolino, Antonino, Giotta, Francesco, Rimanti, Anita, Garrone, Ornella, Bertone,Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-1731
Date:
August, 2020
File:
PDF, 2.77 MB
2020
File converter
More search results
More benefits 
